We found that CEBPB and FGFR2 were differentially elevated in the organoids and bile duct cells of CC patients and HB tumor region, and that elevated expression of FGFR2 and CEBPB may contribute to malignant transformation of CC. Here, CEBPB is linked to cholangiocarcinoma.